Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Gestational Hypertension Management

Definition and Diagnosis

  • The American College of Cardiology defines gestational hypertension as blood pressure ≥140/90 mmHg that appears after 20 weeks of gestation and generally resolves within 42 days postpartum 3
  • Approximately one quarter of gestational hypertension cases progress to preeclampsia, especially those diagnosed before 34 weeks of gestation 1
  • Diagnosis should be based on at least two elevated blood pressure readings on separate occasions 3

Blood Pressure Control

  • Blood pressure ≥160/110 mmHg requires urgent treatment in a monitored setting; acceptable agents include oral nifedipine, labetalol, or intravenous hydralazine 4, 5
  • For blood pressures consistently ≥140/90 mmHg in the clinic (or ≥135/85 mmHg at home), treatment is recommended with a goal diastolic pressure of 85 mmHg and systolic pressure between 110-140 mmHg 4, 2
  • First-line acceptable agents include methyldopa, labetalol, oxprenolol, and nifedipine 4, 2

Maternal Monitoring

  • Regular clinical evaluation, including assessment for clonus 1, 6
  • Urine analysis at each visit to detect proteinuria 1
  • Laboratory tests (hemoglobin, platelet count, liver enzymes, uric acid, and creatinine) at least at 28 and 34 weeks of gestation 1

Fetal Monitoring

  • Evaluation of fetal well-being with ultrasound from 26 weeks of gestation 1, 2
  • Subsequent evaluations every 2-4 weeks if fetal biometry is normal 1
  • More frequent monitoring in the presence of suspected fetal growth restriction 1, 2

Indications for Hospitalization

  • Development of preeclampsia 1
  • Severe hypertension ≥160/110 mmHg 1, 6
  • Neurological signs or symptoms 5
  • Laboratory test abnormalities suggesting disease progression 6, 7

Delivery Planning

  • Delivery can be delayed until 39+6 weeks if blood pressure can be controlled, fetal monitoring is reassuring, and preeclampsia has not developed 1, 2
  • A large retrospective study concluded that the optimal time for delivery is between 38-39 weeks, but this needs clarification with future randomized trials 1

Pharmacological Considerations

  • No relevant facts without [ignore ref] material.

Prevention of Adverse Outcomes

  • No relevant facts without [ignore ref] material or from 'Praxis Medical Insights'.